Small Grants Program

小额赠款计划

• 批准号: 10576207
• 负责人: RICHARD YANAGIHARA
• 金额: $ 19.35万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-03-14 至 2023-07-13
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10576207
• 关键词: Affect; Applications Grants; Asia; Award; Basic Science; Biomedical Research; Center for Translational Science Activities; Centers of Research Excellence; Cessation of life; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communicable Diseases; Data; Development; Diagnostic; Economics; Emerging Communicable Diseases; Epidemic; Extramural Activities; Faculty; Fostering; Funding; Funding Mechanisms; Geographic Locations; Goals; Grant; Guidelines; Hawaii; Infectious Diseases Research; International; Investments; Measures; Mentors; Phase; Phase Transition; Pilot Projects; Prevention strategy; Probability; Process; Productivity; Rapid diagnostics; Research; Research Training; Resource Sharing; Resources; Schools; Science; Scientist; Series; Site; Social Behavior; Talents; Time; Training; Training Programs; Translational Research; Travel; United States National Institutes of Health; Universities; Vaccines; Vision; Work; base; career; career development; clinical infrastructure; data sharing; design; effective therapy; epidemiology study; expectation; experience; flexibility; human capital; improved; meetings; programs; prospective; success; therapeutically effective; translational research program; underserved community

Project Summary for the Small Grants Program During Phases I and II of Centers of Biomedical Research Excellence (COBRE) funding, the Pacific Center for Emerging Infectious Diseases Research (http://pceidr.jabsom.hawaii.edu/) was transformed into a translational science center of excellence for the development of rapid diagnostics, effective therapeutics and affordable vaccines for infectious diseases, that disproportionately affect underserved communities in the Asia-Pacific region. The overall objective of the Phase III COBRE is to enhance the conditions that accelerate the pace of scientific discovery, heighten research productivity and increase competitiveness for extramural funding by sustaining the COBRE cores and implementing a collaborative Small Grants Program. The proposed Small Grants Program will embrace the key tenets of the IDeA Program: namely, to foster collaborative interactions; promote data and resource sharing; identify and disseminate best practices; and develop strategies to identify additional opportunities for core sustainability. Thus, the COBRE Small Grants Program will harness the rich human capital and exceptional core resources at COBRE, IDeA Networks of Biomedical Research Excellence (INBRE) and Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR) programs to conduct team-science research on emerging infectious diseases. To be more responsive to the needs of faculty at different career stages and provide additional opportunities for mentoring and specialized training, the Small Grants Program will offer modest support on a competitive basis through three distinct funding mechanisms: (1) Pilot Projects Program; (2) Bridging Funds Program; and (3) Faculty Exchange Program. A rigorous application and review process, designed according to NIH guidelines, will be implemented to identify the most meritorious science and to select the applicants with the greatest potential for long-term success. At the same time, COBRE Mentors will also provide personalized mentoring to unfunded applicants, thereby optimizing the professional development of local talent for careers in infectious diseases research. Based on our experience in managing collaborative pilot projects and bridging funds program in other NIH center grants, the expectation is that the proposed Small Grants Program will have a significant impact on heightening research productivity and enhancing grants success. A significant return on investment, as measured by extramural funding in the form of R-, U- and K-series grants, will serve as the scientific and economic engines to drive future research and funding to sustain the Center and its cores.

小额赠款计划项目摘要 在生物医学研究卓越中心（COBRE）资助的第一和第二阶段，太平洋中心 新兴传染病研究（http：//pceidr.jabsom.hawaii.edu/）被转化为翻译 卓越科学中心，用于开发快速诊断，有效治疗和负担得起的 对亚太地区服务不足社区造成不成比例影响的传染病疫苗 地区COBRE第三阶段的总体目标是改善条件，加快 科学发现，提高研究生产力，增加校外资金的竞争力， 维持COBRE核心并实施协作性小额赠款计划。建议的小 赠款计划将包括IDEA计划的主要原则：即，促进合作互动; 促进数据和资源共享;确定和传播最佳做法;制定战略， 核心可持续性的更多机会。 因此，COBRE小额赠款计划将利用丰富的人力资本和特殊的核心资源， COBRE，IDEA生物医学研究卓越网络（INBRE）和机构发展奖 临床和转化研究计划基础设施（IDEA-CTR）计划，以进行团队科学 研究新发传染病。更好地满足不同职业教师的需求 小额赠款计划是一个多阶段的项目，提供更多的辅导和专门培训机会， 将通过三种不同的供资机制，在竞争基础上提供适度的支持：（1）试点项目 计划;（2）过渡基金计划;（3）教师交流计划。严格的申请和审查 根据NIH指南设计的过程将被实施，以确定最有价值的科学 并挑选最有潜力取得长期成功的申请人。与此同时，COBRE 导师还将为没有资金的申请人提供个性化的指导，从而优化专业知识。 发展本地传染病研究人才。 根据我们在管理其他NIH合作试点项目和桥接基金项目方面的经验， 中心赠款，预计拟议的小额赠款计划将产生重大影响， 提高研究生产力和提高赠款的成功率。投资回报率高，如 通过R-，U-和K-系列赠款形式的校外资金来衡量，将作为科学和 经济引擎，以推动未来的研究和资金，以维持中心及其核心。